CoChat

TRPA1 mediates the hypothermic action of acetaminophen

Open access
Gentry, Clive, Andersson, David A., Bevan, Stuart · 2015 · Scientific Reports

The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.

Abstract

Acetaminophen (APAP) is an effective antipyretic and one of the most commonly used analgesic drugs. Unlike antipyretic non-steroidal anti-inflammatory drugs, APAP elicits hypothermia in addition to its antipyretic effect. Here we have examined the mechanisms responsible for the hypothermic activity of APAP. Subcutaneous, but not intrathecal, administration of APAP elicited a dose dependent decrease in body temperature in wildtype mice. Hypothermia was abolished in mice pre-treated with resiniferatoxin to destroy or defunctionalize peripheral TRPV1-expressing terminals, but resistant to inhibition of cyclo-oxygenases. The hypothermic activity was independent of TRPV1 since APAP evoked hypothermia was identical in wildtype and Trpv1−/−mice and not reduced by administration of a maximally effective dose of a TRPV1 antagonist. In contrast, a TRPA1 antagonist inhibited APAP induced hypothermia and APAP was without effect on body temperature in Trpa1−/−mice. In a model of yeast induced pyrexia, administration of APAP evoked a marked hypothermia in wildtype and Trpv1−/−mice, but only restored normal body temperature in Trpa1−/−and Trpa1−/−/Trpv1−/−mice. We conclude that TRPA1 mediates APAP evoked hypothermia.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/srep12771

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 APAP elicits TRPA1-dependent hypothermia. (A) Subcutaneous injections of APAP evoked a dose-dependent hypothermia in C57BL/6J mice (n = 6–12). (B) APAP (300 mg/kg) reduced the body temperature in Trpa1+/+ mice but was without effect in Trpa1−/− mice (n = 6–11, see panel C for key to the symbols). (C) Intrathecal administration of APAP (100μg) did not reduce body temperature (n = 6). (D) Resiniferatoxin (RTX, 6.3 μg/kg, s.c.) induced a profound hypothermia in Trpa1+/+ and Trpa1−/− mice (n = 6). (E) APAP (300 mg/kg s.c.) evoked hypothermia in non-RTX treated Trpa1+/+ mice, but was without effect in Trpa1−/− and RTX treated Trpa1+/+ mice (n = 6). (F) Indomethacin (10 mg/kg, s.c.) did not alter body temperature and did not inhibit APAP (300mg/kg) evoked hypothermia (n = 6). (G) Oral administration of the TRPA1 antagonist CHEM5861528 (40–300 mg/kg, 45 min before APAP) produced a dose-dependent inhibition of APAP evoked hypothermia (n = 6). (H) Intraperitoneal injections of the TRPA1 agonist cinnamaldehyde (CA, 125 mg/kg) induced a marked hypothermia in Trpa1+/+ mice, which was significantly reduced in Trpa1−/− mice (n = 6). Data are mean ± sem; *p < 0.05, **p < 0.01, ***p < 0.001 compared to vehicle and †p < 0.05, ††p < 0.01, †††p < 0.001 compared to Trpa1+/+.
Figure 1 APAP elicits TRPA1-dependent hypothermia. (A) Subcutaneous injections of APAP evoked a dose-dependent hypothermia in C57BL/6J mice (n = 6–12). (B) APAP (300 mg/kg) reduced the body temperature in Trpa1+/+ mice but was without effect in Trpa1−/− mice (n = 6–11, see panel C for key to the symbols). (C) Intrathecal administration of APAP (100μg) did not reduce body temperature (n = 6). (D) Resiniferatoxin (RTX, 6.3 μg/kg, s.c.) induced a profound hypothermia in Trpa1+/+ and Trpa1−/− mice (n = 6). (E) APAP (300 mg/kg s.c.) evoked hypothermia in non-RTX treated Trpa1+/+ mice, but was without effect in Trpa1−/− and RTX treated Trpa1+/+ mice (n = 6). (F) Indomethacin (10 mg/kg, s.c.) did not alter body temperature and did not inhibit APAP (300mg/kg) evoked hypothermia (n = 6). (G) Oral administration of the TRPA1 antagonist CHEM5861528 (40–300 mg/kg, 45 min before APAP) produced a dose-dependent inhibition of APAP evoked hypothermia (n = 6). (H) Intraperitoneal injections of the TRPA1 agonist cinnamaldehyde (CA, 125 mg/kg) induced a marked hypothermia in Trpa1+/+ mice, which was significantly reduced in Trpa1−/− mice (n = 6). Data are mean ± sem; *p < 0.05, **p < 0.01, ***p < 0.001 compared to vehicle and †p < 0.05, ††p < 0.01, †††p < 0.001 compared to Trpa1+/+.CC BY · PubMed Central
Figure 2 APAP induces hypothermia independently of TRPV1. (A) Oral administration of the TRPV1 antagonist BCTP (30 mg/kg) elicited hyperthermia in C57BL/6J mice (n = 6), but did not inhibit the hypothermia produced by a subsequent dose of APAP (300 mg/kg). (B) APAP (300 mg/kg) evoked identical hypothermia in Trpv1+/+ and Trpv1−/− mice (n = 6). Data are mean ± sem; *p < 0.05, **p < 0.01, ***p < 0.001 compared to vehicle (ANOVA followed by Tukey’s HSD test).
Figure 2 APAP induces hypothermia independently of TRPV1. (A) Oral administration of the TRPV1 antagonist BCTP (30 mg/kg) elicited hyperthermia in C57BL/6J mice (n = 6), but did not inhibit the hypothermia produced by a subsequent dose of APAP (300 mg/kg). (B) APAP (300 mg/kg) evoked identical hypothermia in Trpv1+/+ and Trpv1−/− mice (n = 6). Data are mean ± sem; *p < 0.05, **p < 0.01, ***p < 0.001 compared to vehicle (ANOVA followed by Tukey’s HSD test).CC BY · PubMed Central
Figure 3 Antipyretic and hypothermic activity of APAP in yeast induced hyperthermia. Administration of yeast (2 g/kg) produced hyperthermia in wildtype, Trpv1−/− and Trpa1−/− mice. (A) APAP (300 mg/kg) produced hypothermia in both hyperthermic Trpv1+/+ and Trpv1−/− mice (n = 8). (B) APAP produced hypothermia in Trpa1+/+ mice, but acted as an antipyretic, restoring normal, pre-yeast injection, temperature in Trpa1−/− mice. Dashed lines indicate pre-yeast body temperature. Data are mean ± sem; *p < 0.05, **p < 0.01, ***p < 0.001 compared to pre-yeast injection and ††p < 0.01, †††p < 0.001 compared to Trpa1+/+ (ANOVA followed by Tukey’s HSD test). For clarity, some symbols indicating statistical significance have been omitted from (B).
Figure 3 Antipyretic and hypothermic activity of APAP in yeast induced hyperthermia. Administration of yeast (2 g/kg) produced hyperthermia in wildtype, Trpv1−/− and Trpa1−/− mice. (A) APAP (300 mg/kg) produced hypothermia in both hyperthermic Trpv1+/+ and Trpv1−/− mice (n = 8). (B) APAP produced hypothermia in Trpa1+/+ mice, but acted as an antipyretic, restoring normal, pre-yeast injection, temperature in Trpa1−/− mice. Dashed lines indicate pre-yeast body temperature. Data are mean ± sem; *p < 0.05, **p < 0.01, ***p < 0.001 compared to pre-yeast injection and ††p < 0.01, †††p < 0.001 compared to Trpa1+/+ (ANOVA followed by Tukey’s HSD test). For clarity, some symbols indicating statistical significance have been omitted from (B).CC BY · PubMed Central
Figure 4 Effect of APAP and indomethacin in hyperthermic Trpa1−/−/Trpv1−/− mice. (A–C) Administration of yeast (2 g/kg) produced hyperthermia in wildtype and Trpa1−/−/Trpv1−/− mice. (A) APAP (300 mg/kg) evoked hypothermia in wildtype mice, but only restored normal body temperature in Trpa1−/−/Trpv1−/− mice (n = 6). (B) The antipyretic indomethacin (30 mg/kg) restored pre-yeast injection temperature in wildtype and Trpa1−/−/Trpv1−/− mice (n = 6). In Trpa1−/−/Trpv1−/− mice, this was later followed by a slow reduction in body temperature. (C) Adminstration of APAP (300 mg/kg) 1h after indomethacin (30 mg/kg) rapidly elicited hypothermia in wildtype, but not Trpa1−/−/Trpv1−/− mice (n = 6). The slow reduction in body temperature in Trpa1−/−/Trpv1−/− mice was not different from that seen in (B) in animals receiving vehicle instead of APAP. Data are mean ± sem; *p < 0.05, **p < 0.01, ***p < 0.001 compared to pre-yeast injection and †p < 0.05, ††p < 0.01, †††p < 0.001 compared to Trpa1+/+ (ANOVA followed by Tukey’s HSD test).
Figure 4 Effect of APAP and indomethacin in hyperthermic Trpa1−/−/Trpv1−/− mice. (A–C) Administration of yeast (2 g/kg) produced hyperthermia in wildtype and Trpa1−/−/Trpv1−/− mice. (A) APAP (300 mg/kg) evoked hypothermia in wildtype mice, but only restored normal body temperature in Trpa1−/−/Trpv1−/− mice (n = 6). (B) The antipyretic indomethacin (30 mg/kg) restored pre-yeast injection temperature in wildtype and Trpa1−/−/Trpv1−/− mice (n = 6). In Trpa1−/−/Trpv1−/− mice, this was later followed by a slow reduction in body temperature. (C) Adminstration of APAP (300 mg/kg) 1h after indomethacin (30 mg/kg) rapidly elicited hypothermia in wildtype, but not Trpa1−/−/Trpv1−/− mice (n = 6). The slow reduction in body temperature in Trpa1−/−/Trpv1−/− mice was not different from that seen in (B) in animals receiving vehicle instead of APAP. Data are mean ± sem; *p < 0.05, **p < 0.01, ***p < 0.001 compared to pre-yeast injection and †p < 0.05, ††p < 0.01, †††p < 0.001 compared to Trpa1+/+ (ANOVA followed by Tukey’s HSD test).CC BY · PubMed Central
Figure 5 Hypothermic effects of other agents. The CB1 and CB2 receptor agonist WIN55,212-2 (A), the opioid receptor agonist morphine (B) and the general anaesthetic isoflurane (C) produced a marked hypothermia in Trpa1+/+ and Trpa1−/− mice (n = 6).
Figure 5 Hypothermic effects of other agents. The CB1 and CB2 receptor agonist WIN55,212-2 (A), the opioid receptor agonist morphine (B) and the general anaesthetic isoflurane (C) produced a marked hypothermia in Trpa1+/+ and Trpa1−/− mice (n = 6).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 46 references

Cited by

See all 50

Metadata

Authors
Gentry, C., Andersson, D. A., & Bevan, S.
Affiliations
King's College London (GB)
Corresponding author
Andersson, David A.
Venue
Scientific Reports
Published
2015-07-31
Volume
5
Issue
1
Pages
12771-12771
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2304426385
Cited by
50
References
45
Citations by year
2026: 3 · 2025: 6 · 2024: 2 · 2023: 1 · 2022: 4 · 2021: 6 · 2020: 6 · 2019: 4 · 2018: 7 · 2017: 8 · 2016: 3
FWCI
3.90
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Research Portal (King's College London) (publishedVersion, cc-by)
Topics
  • Life Sciences › Neuroscience › Sensory Systems › Ion Channels and Receptors
  • Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Thermal Regulation in Medicine
  • Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
Keywords
paracetamol, TRPA1, hypothermia, TRPV1, thermoregulation, fever, antipyretic mechanism, TRPA1 antagonists, subcutaneous administration
MeSH terms
TRPA1 Cation Channel, Acetaminophen, Acrolein, Animals, Diterpenes, Female, Hypothermia, Hypothermia, Induced, Imines, Injections, Intraperitoneal, Injections, Subcutaneous, Male, Mice, Inbred C57BL, Mice, Mutant Strains, Sensory Receptor Cells, Benzoquinones, Transient Receptor Potential Channels, TRPV Cation Channels, Antipyretics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.